As of January 15, the Congressionally Directed Medical Research Programs (CDMRP) has only announced one active funding program. The
FY20 Breast Cancer Research Program (BCRP) program announcements were released on December 23, 2019. Five (5) separate mechanisms have been announced. These are:
Breakthrough Award Levels 1 and 2
Mandatory Letter of Intent Due: March 12, 2020
Application Due: March 26, 2020
Breakthrough Award Level 3
Mandatory Letter of Intent Due: March 13, 2020
Application Due: June 24, 2020
Breakthrough Award Level 4
Mandatory Letter of Intent Due: March 13, 2020
Application Due: June 24, 2020
Era of Hope Award
Mandatory Letter of Intent Due: March 12, 2020
Application Due: March 26, 2020
Confidential Letter if Recommendation Due: March 30, 2020
Innovator Award
Mandatory Letter of Intent Due: March 13, 2020
Application Due: June 24, 2020
Confidential Letter if Recommendation Due: June 26, 2020
CDMRP has released the following pre-announcements. Pre-announcements are made to allow investigators time to plan and develop ideas for submission to the anticipated FY20 funding opportunities.
These programs are not active at this time. Once they become active, links and deadlines will be published on this blog.
Amyotrophic Lateral Sclerosis Research Program (ALSRP)
* Therapeutic Idea Award
* Therapeutic Development Award
* New in FY20! Clinical Development Award
Autism Research Program (ARP)
* Clinical Trial Award
* Clinical Translational Research Award
* Idea Development Award
Bone Marrow Failure Research Program (BMFRP)
* Idea Development Award
Military Burn Research Program (MBRP)
* Clinical Translational Research Award
Peer Reviewed Medical Research Program (PRMRP)
* Clinical Trial Award
* Discovery Award
* Focused Program Award
* Investigator-Initiated Research Award
* Technology/Therapeutic Development Award
Orthotics and Prosthetics Outcomes Research Program (OPORP)
* Clinical Research Award
* Clinical Trial Award
Remember to check back on the blog for details as these are released.